A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

Name: A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19
License: Public Domain

ModernaTX, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

sars-cov-2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 329585
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.